Cary Miller Ph.D.

Tillis Urges FDA, USPTO To Investigate Potential False Narrative By Drug Critics

Inducement Suit Proceeds Against Insurance Company For Encouraging Use Of Generic Drug

Executive Order On Promoting Competition In The American Economy: A Focus On Patent And Drug Law To Reduce Health Care Spending

Federal Circuit Vacates Judgment, Reinstates Jury's Verdict Of Induced Infringement

FDA Launches Review Of Orange Book Patent Listing Practices

IPR Estoppel Applies Even After A Bench Trial On Validity

Communications With, And Criticism By, FDA In Analyzing Obviousness

Polymorph Patent Not Invalid As Obvious

New PTAB Pilot Program For Claim Amendments

PTAB Upholds GILENYA™ Method Of Treatment Patent, Prompting New ANDA Litigation